Form 483

CA BOTANA International, Inc. Form 483, 2019-11-12

FDA issued a Form 483 to CA BOTANA International, Inc. on 2019-11-12 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

CA BOTANA International, Inc. · San Diego, United States · Issued November 12, 2019

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Nov 2019
21 CFR 211.150(b)

Recall facilitation

Cited by Diane R Weidley

12 Nov 2019
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Diane R Weidley

12 Nov 2019
21 CFR 211.165(f)

Failing drug products not rejected

Cited by Diane R Weidley

12 Nov 2019
21 CFR 211.182

Written records kept in individual logs

Cited by Diane R Weidley

12 Nov 2019
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Diane R Weidley

Inspected site

CBCA BOTANA International, Inc.San Diego, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.150(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(f)Cited across public-safe Form 483 observations1x
21 CFR 211.182Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.89Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere